Register entry

Bavarian Nordic A/S

Data as of · How to read this entry

Registered sites
3
Active NDC listings
10
Live patents
0
Countries
3
Base
Germany
Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture2Labelling2Finished drug manufacture2Packaging2
Sites

Registered establishments

3
EstablishmentAddressRegistered forFEI / DUNS
Bavarian Nordic Berna GmbHRegistrant: Bavarian Nordic A/SOberriedstrasse 68, Th�rishaus, Bern 3174, Switzerland (CHE)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3011237656480030654
Bavarian Nordic GmbHRegistrant: Bavarian Nordic A/SFraunhoferstra�e 13, Martinsried, 82152, Germany (DEU)Analytical testing3005565792314328944
Bavarian Nordic A/SHejreskovvej 10A, Kvistgaard, Denmark 3490, Denmark (DNK)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3008318564306197198
Catalogue

Drug listings by form and route

10

10 active NDC listings: 10 vaccine. By marketing category: BLA 10.

Dosage formNDCs
injection, suspension4
injection, powder, lyophilized, for suspension2
kit2
capsule, coated1
liquid1
RouteNDCs
subcutaneous6
intramuscular1
oral1
Labeller name on the listingNDCs
bavarian nordic a/s10
Catalogue

Marketed products

10
BrandGeneric nameForm / routeNDC
Diluent ComponentWater for Injectionliquid, subcutaneous50632-003BLA
JYNNEOSVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigeninjection, suspension, subcutaneous50632-001BLA
JYNNEOSVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigeninjection, powder, lyophilized, for suspension, subcutaneous50632-002BLA
JYNNEOSVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigeninjection, suspension, subcutaneous50632-022BLA
JYNNEOSVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigeninjection, suspension, subcutaneous50632-023BLA
JYNNEOSVaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigeninjection, powder, lyophilized, for suspension, subcutaneous50632-024BLA
RabAvertRabies Vaccinekit50632-010BLA
VIMKUNYAChikungunya Vaccine, Recombinantinjection, suspension, intramuscular50632-018BLA
VaxchoraCholera Vaccine, Live, Oralkit50632-015BLA
VivotifSalmonella typhi Ty21acapsule, coated, oral50632-016BLA
Compare

Comparable companies in Germany

Enquiry

Common questions

Is Bavarian Nordic A/S FDA approved?
Bavarian Nordic A/S holds 3 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Bavarian Nordic A/S's drugs manufactured?
At registered sites in Switzerland, Germany, Denmark. The FDA register lists Th�rishaus; Martinsried; Kvistgaard. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Bavarian Nordic A/S make?
10 products are listed under Bavarian Nordic A/S in the openFDA NDC Directory, most often as injection, suspension; injection, powder, lyophilized, for suspension; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.